TORONTO -- (MARKET WIRE) -- March 19, 2007 -- Generex Biotechnology Corporation (NASDAQ: GNBT) announced today that Dr. Douglas Powell, Ph.D., Director of Immunobiology at Antigen Express, Inc., the Company's wholly owned immunotherapeutics subsidiary, will make a presentation at the World Vaccine Congress 2007 to be held in Washington, D.C., March 19th and 20th. The Company recently began treating volunteers in a clinical trial of the first synthetic avian influenza vaccine to be tested in humans.
